Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 5/2018

17.05.2018 | ORIGINAL ARTICLE

Risk factors associated with intrathyroid extension of thyroid microcarcinomas

verfasst von: Nikola Slijepcevic, Vladan Zivaljevic, Aleksandar Diklic, Milan Jovanovic, Branislav Oluic, Ivan Paunovic

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aims of this study were to investigate the rate of intrathyroid extension of papillary thyroid microcarcinoma (PTMC) in patients operated for benign thyroid disease and to identify independent risk factors associated with it.

Methods

A retrospective study of 301 patients operated for benign thyroid diseases (hyperthyroid diseases, multinodular goitre, Hashimoto thyroiditis and benign thyroid tumours) was performed at a high-volume endocrine surgery unit of a tertiary referral academic hospital, in a 5-year period. These patients had a PTMC incidentally discovered on definite histopathological findings following total or near-total thyroidectomy. Since distinguishing between intrathyroid extension of PTMC as the result of intrathyroid dissemination or as the result of multicentricity is challenging, we observed them together as multifocality. In statistical analysis, we used standard descriptive statistics and univariate and multivariate logistic regression analysis to determine independent risk factors associated with multifocality.

Results

In our study, there were 85.4% females and 14.6% males with a median age of 54 years. A multinodular goitre (32.5%) was the most common indication for an operation. Most patients (68.4%) had a PTMC that was 5 mm or smaller. The most frequent histological variants of PTMC were the follicular variant (52.8%), followed by the papillary variant (22.6%) and the mixed follicular-papillary variant (18.6%). A multifocal PTMC was present in 26.6% of cases. An independent protective factor for multifocality of PTMC was a thyroid gland that weighed more than 38 g (OR 0.55, 95% CI 0.31–0.97, p = 0.039). Size of PTMC greater than 5 mm was an independent risk factor for a multifocal PTMC (OR 3.26, 95% CI 1.85–5.75, p = 0.000). Finally, the mixed follicular-papillary variant of PTMC represents an independent risk factor for a multifocal PTMC (OR 2.42, 95% CI 1.09–5.36, p = 0.030).

Conclusions

Intrathyroid extension is present in more than a quarter of PTMCs found in patients operated for benign thyroid disease. Independent risk factors for intrathyroid extension are size of PTMC greater than 5 mm and the mixed follicular-papillary variant of PTMC, while a large thyroid gland is an independent protective factor.
Literatur
1.
Zurück zum Zitat El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ (2017) The fourth edition of the head and neck World Health Organization blue book: editors’ perspectives. Hum Pathol 66:10–12CrossRefPubMed El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ (2017) The fourth edition of the head and neck World Health Organization blue book: editors’ perspectives. Hum Pathol 66:10–12CrossRefPubMed
2.
Zurück zum Zitat Slijepcevic N, Zivaljevic V, Paunovic I, Diklic A, Zivkovic P, Miljus D, Grgurevic A, Sipetic S (2016) Rising incidence of thyroid cancer in Serbia. Hippokratia 20(1):9–23PubMedPubMedCentral Slijepcevic N, Zivaljevic V, Paunovic I, Diklic A, Zivkovic P, Miljus D, Grgurevic A, Sipetic S (2016) Rising incidence of thyroid cancer in Serbia. Hippokratia 20(1):9–23PubMedPubMedCentral
3.
Zurück zum Zitat Bernet V (2010) Approach to the patient with incidental papillary microcarcinoma. J Clin Endocrinol Metab 95(8):3586–3592CrossRefPubMed Bernet V (2010) Approach to the patient with incidental papillary microcarcinoma. J Clin Endocrinol Metab 95(8):3586–3592CrossRefPubMed
4.
Zurück zum Zitat Jung CK, Little MP, Lubin JH, Brenner AV, Wells SA Jr, Sigurdson AJ, Nikiforov YE (2014) The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J Clin Endocrinol Metab 99(2):E276–E285CrossRefPubMed Jung CK, Little MP, Lubin JH, Brenner AV, Wells SA Jr, Sigurdson AJ, Nikiforov YE (2014) The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J Clin Endocrinol Metab 99(2):E276–E285CrossRefPubMed
5.
Zurück zum Zitat Baloch ZW, Harrell RM, Brett EM, Randolph G, Garber JR, Committee AESS, Thyroid Scientific C (2017) American Association of Clinical Endocrinologists and American College of Endocrinology Disease state commentary: managing thyroid tumors diagnosed as noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Endocr Pract 23(9):1150–1155CrossRefPubMed Baloch ZW, Harrell RM, Brett EM, Randolph G, Garber JR, Committee AESS, Thyroid Scientific C (2017) American Association of Clinical Endocrinologists and American College of Endocrinology Disease state commentary: managing thyroid tumors diagnosed as noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Endocr Pract 23(9):1150–1155CrossRefPubMed
6.
Zurück zum Zitat Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid : Off J Am Thyroid Assoc 26(1):1–133CrossRef Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid : Off J Am Thyroid Assoc 26(1):1–133CrossRef
7.
Zurück zum Zitat Roti E, degli Uberti EC, Bondanelli M, Braverman LE (2008) Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eu J Endocrinol / Eur Fed Endocrine Soc 159(6):659–673CrossRef Roti E, degli Uberti EC, Bondanelli M, Braverman LE (2008) Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eu J Endocrinol / Eur Fed Endocrine Soc 159(6):659–673CrossRef
8.
Zurück zum Zitat Slijepcevic N, Zivaljevic V, Marinkovic J, Sipetic S, Diklic A, Paunovic I (2015) Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid surgery for presumed benign thyroid disease. BMC Cancer 15(1):330CrossRefPubMedPubMedCentral Slijepcevic N, Zivaljevic V, Marinkovic J, Sipetic S, Diklic A, Paunovic I (2015) Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid surgery for presumed benign thyroid disease. BMC Cancer 15(1):330CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Tarasova VD, Tuttle RM (2017) Current management of low risk differentiated thyroid cancer and papillary microcarcinoma. Clin Oncol (R Coll Radiol) 29(5):290–297CrossRef Tarasova VD, Tuttle RM (2017) Current management of low risk differentiated thyroid cancer and papillary microcarcinoma. Clin Oncol (R Coll Radiol) 29(5):290–297CrossRef
10.
Zurück zum Zitat Ito Y, Kudo T, Kihara M, Takamura Y, Kobayashi K, Miya A, Miyauchi A (2012) Prognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumors. Endocr J 59(2):119–125CrossRefPubMed Ito Y, Kudo T, Kihara M, Takamura Y, Kobayashi K, Miya A, Miyauchi A (2012) Prognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumors. Endocr J 59(2):119–125CrossRefPubMed
11.
Zurück zum Zitat Kaliszewski K, Strutynska-Karpinska M, Zubkiewicz-Kucharska A, Wojtczak B, Domoslawski P, Balcerzak W, Lukienczuk T, Forkasiewicz Z (2016) Should the prevalence of incidental thyroid cancer determine the extent of surgery in multinodular goiter? PLoS One 11(12):e0168654CrossRefPubMedPubMedCentral Kaliszewski K, Strutynska-Karpinska M, Zubkiewicz-Kucharska A, Wojtczak B, Domoslawski P, Balcerzak W, Lukienczuk T, Forkasiewicz Z (2016) Should the prevalence of incidental thyroid cancer determine the extent of surgery in multinodular goiter? PLoS One 11(12):e0168654CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Iida F, Yonekura M, Miyakawa M (1969) Study of intraglandular dissemination of thyroid cancer. Cancer 24(4):764–771CrossRefPubMed Iida F, Yonekura M, Miyakawa M (1969) Study of intraglandular dissemination of thyroid cancer. Cancer 24(4):764–771CrossRefPubMed
13.
Zurück zum Zitat Melliere D, Hindie E, Becquemin JP, Desgranges P, Allaire E, Geachan E (2006) Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients. Bull Acad Natl Med 190(1):89–106 discussion 106-109PubMed Melliere D, Hindie E, Becquemin JP, Desgranges P, Allaire E, Geachan E (2006) Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients. Bull Acad Natl Med 190(1):89–106 discussion 106-109PubMed
14.
Zurück zum Zitat Can N, Tastekin E, Ozyilmaz F, Sezer YA, Guldiken S, Sut N, Sarikas N, Oz Puyan F, Guler B, Ayturk S, Celik M (2015) Histopathological evidence of lymph node metastasis in papillary thyroid carcinoma. Endocr Pathol 26(3):218–228CrossRefPubMed Can N, Tastekin E, Ozyilmaz F, Sezer YA, Guldiken S, Sut N, Sarikas N, Oz Puyan F, Guler B, Ayturk S, Celik M (2015) Histopathological evidence of lymph node metastasis in papillary thyroid carcinoma. Endocr Pathol 26(3):218–228CrossRefPubMed
15.
Zurück zum Zitat Hirokawa M, Kudo T, Ota H, Suzuki A, Miyauchi A (2016) Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance. Endocr J 63(9):805–810CrossRefPubMed Hirokawa M, Kudo T, Ota H, Suzuki A, Miyauchi A (2016) Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance. Endocr J 63(9):805–810CrossRefPubMed
16.
Zurück zum Zitat Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ (1992) Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112(6):1139–1146 discussion 1146-1137PubMed Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ (1992) Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112(6):1139–1146 discussion 1146-1137PubMed
17.
Zurück zum Zitat Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, Cailleux AF, Lumbroso JD, Parmentier C, Schlumberger M (1998) Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83(3):553–559CrossRefPubMed Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, Cailleux AF, Lumbroso JD, Parmentier C, Schlumberger M (1998) Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83(3):553–559CrossRefPubMed
18.
Zurück zum Zitat Sugitani I, Fujimoto Y (1999) Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr J 46(1):209–216CrossRefPubMed Sugitani I, Fujimoto Y (1999) Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr J 46(1):209–216CrossRefPubMed
19.
Zurück zum Zitat Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H (1996) Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Arch Surg 131(2):187–191CrossRefPubMed Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H (1996) Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Arch Surg 131(2):187–191CrossRefPubMed
20.
Zurück zum Zitat Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104(6):947–953CrossRefPubMed Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104(6):947–953CrossRefPubMed
21.
Zurück zum Zitat Verburg FA, Mader U, Luster M, Reiners C (2009) Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma. Clin Endocrinol 71(2):291–297CrossRef Verburg FA, Mader U, Luster M, Reiners C (2009) Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma. Clin Endocrinol 71(2):291–297CrossRef
22.
Zurück zum Zitat Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A (2004) Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89(8):3713–3720CrossRefPubMed Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A (2004) Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89(8):3713–3720CrossRefPubMed
23.
Zurück zum Zitat Jukkola A, Bloigu R, Ebeling T, Salmela P, Blanco G (2004) Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 11(3):571–579CrossRefPubMed Jukkola A, Bloigu R, Ebeling T, Salmela P, Blanco G (2004) Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 11(3):571–579CrossRefPubMed
24.
Zurück zum Zitat Baser H, Ozdemir D, Cuhaci N, Aydin C, Ersoy R, Kilicarslan A, Cakir B (2015) Hashimoto’s thyroiditis does not affect ultrasonographical, cytological, and histopathological features in patients with papillary thyroid carcinoma. Endocr Pathol 26:356–364CrossRefPubMed Baser H, Ozdemir D, Cuhaci N, Aydin C, Ersoy R, Kilicarslan A, Cakir B (2015) Hashimoto’s thyroiditis does not affect ultrasonographical, cytological, and histopathological features in patients with papillary thyroid carcinoma. Endocr Pathol 26:356–364CrossRefPubMed
25.
Zurück zum Zitat Lin JD (2010) Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer. Med Oncol 27(2):510–518CrossRefPubMed Lin JD (2010) Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer. Med Oncol 27(2):510–518CrossRefPubMed
26.
Zurück zum Zitat Kasai N, Sakamoto A (1987) New subgrouping of small thyroid carcinomas. Cancer 60(8):1767–1770CrossRefPubMed Kasai N, Sakamoto A (1987) New subgrouping of small thyroid carcinomas. Cancer 60(8):1767–1770CrossRefPubMed
27.
Zurück zum Zitat Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237(3):399–407PubMedPubMedCentral Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237(3):399–407PubMedPubMedCentral
28.
Zurück zum Zitat Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH (2003) Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer 98(1):31–40CrossRefPubMed Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH (2003) Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer 98(1):31–40CrossRefPubMed
29.
Zurück zum Zitat Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, Pearce EN, Braverman LE, Degli Uberti EC (2006) Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab 91(6):2171–2178CrossRefPubMed Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, Pearce EN, Braverman LE, Degli Uberti EC (2006) Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab 91(6):2171–2178CrossRefPubMed
30.
Zurück zum Zitat Besic N, Pilko G, Petric R, Hocevar M, Zgajnar J (2008) Papillary thyroid microcarcinoma: prognostic factors and treatment. J Surg Oncol 97(3):221–225CrossRefPubMed Besic N, Pilko G, Petric R, Hocevar M, Zgajnar J (2008) Papillary thyroid microcarcinoma: prognostic factors and treatment. J Surg Oncol 97(3):221–225CrossRefPubMed
31.
Zurück zum Zitat Duran AO, Anil C, Gursoy A, Nar A, Altundag O, Inanc M, Bozkurt O, Tutuncu NB (2014) The relationship between thyroid volume and malignant thyroid disease. Med Oncol 31(1):814CrossRefPubMed Duran AO, Anil C, Gursoy A, Nar A, Altundag O, Inanc M, Bozkurt O, Tutuncu NB (2014) The relationship between thyroid volume and malignant thyroid disease. Med Oncol 31(1):814CrossRefPubMed
32.
Zurück zum Zitat Shi X, Liu R, Basolo F, Giannini R, Shen X, Teng D, Guan H, Shan Z, Teng W, Musholt TJ et al (2015) Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants. J Clin Endocrinol Metab :jc20152917 Shi X, Liu R, Basolo F, Giannini R, Shen X, Teng D, Guan H, Shan Z, Teng W, Musholt TJ et al (2015) Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants. J Clin Endocrinol Metab :jc20152917
34.
Zurück zum Zitat Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, Reinalda ME, Grant CS, Thompson GB, Sebo TJ, Goellner JR (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144(6):980–987 discussion 987-988CrossRefPubMed Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, Reinalda ME, Grant CS, Thompson GB, Sebo TJ, Goellner JR (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144(6):980–987 discussion 987-988CrossRefPubMed
35.
Zurück zum Zitat Mazzaferri EL (2007) Management of low-risk differentiated thyroid cancer. Endocr Pract 13(5):498–512CrossRefPubMed Mazzaferri EL (2007) Management of low-risk differentiated thyroid cancer. Endocr Pract 13(5):498–512CrossRefPubMed
36.
Zurück zum Zitat Roh JL, Kim JM, Park CI (2008) Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol 15(9):2482–2486CrossRefPubMed Roh JL, Kim JM, Park CI (2008) Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol 15(9):2482–2486CrossRefPubMed
37.
Zurück zum Zitat Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474CrossRefPubMed Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474CrossRefPubMed
38.
Zurück zum Zitat Cheema Y, Repplinger D, Elson D, Chen H (2006) Is tumor size the best predictor of outcome for papillary thyroid cancer? Ann Surg Oncol 13(11):1524–1528CrossRefPubMed Cheema Y, Repplinger D, Elson D, Chen H (2006) Is tumor size the best predictor of outcome for papillary thyroid cancer? Ann Surg Oncol 13(11):1524–1528CrossRefPubMed
39.
Zurück zum Zitat Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM, American Thyroid Association Guidelines Taskforce (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid : Off J Am Thyroid Assoc 16(2):109–142CrossRef Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM, American Thyroid Association Guidelines Taskforce (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid : Off J Am Thyroid Assoc 16(2):109–142CrossRef
40.
Zurück zum Zitat Wang TS, Goffredo P, Sosa JA, Roman SA: Papillary thyroid microcarcinoma: an over-treated malignancy? World journal of surgery 2014 Wang TS, Goffredo P, Sosa JA, Roman SA: Papillary thyroid microcarcinoma: an over-treated malignancy? World journal of surgery 2014
41.
Zurück zum Zitat American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid : Off J Am Thyroid Assoc 19(11):1167–1214CrossRef American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid : Off J Am Thyroid Assoc 19(11):1167–1214CrossRef
42.
Zurück zum Zitat DeLellis R, Lloyd R, Heitz P, Eng C (2004) Pathology and genetics of tumors of endocrine organs. IARC Press, Lyon DeLellis R, Lloyd R, Heitz P, Eng C (2004) Pathology and genetics of tumors of endocrine organs. IARC Press, Lyon
43.
Zurück zum Zitat Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid : Off J Am Thyroid Assoc 13(4):381–387CrossRef Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid : Off J Am Thyroid Assoc 13(4):381–387CrossRef
44.
Zurück zum Zitat Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, Tomoda C, Takamura Y, Kobayashi K, Miya A (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34(1):28–35CrossRefPubMed Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, Tomoda C, Takamura Y, Kobayashi K, Miya A (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34(1):28–35CrossRefPubMed
45.
Zurück zum Zitat Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y (2010) Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 34(6):1222–1231CrossRefPubMed Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y (2010) Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 34(6):1222–1231CrossRefPubMed
Metadaten
Titel
Risk factors associated with intrathyroid extension of thyroid microcarcinomas
verfasst von
Nikola Slijepcevic
Vladan Zivaljevic
Aleksandar Diklic
Milan Jovanovic
Branislav Oluic
Ivan Paunovic
Publikationsdatum
17.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 5/2018
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-018-1680-3

Weitere Artikel der Ausgabe 5/2018

Langenbeck's Archives of Surgery 5/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.